Learn More
Medchemexpress LLC N-3-pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxamide | 1196109-52-0 | MFCD21365072 | >98.0% | 456.46 g/mol | C24H23F3N4O2 | 5 MG

Supplier: Medchemexpress LLC HY143805MG
PF-3845 is a selective, irreversible fatty acid amide hydrolase (FAAH) inhibitor for research use. It covalently carbamylates the catalytic serine of FAAH, elevating endocannabinoid levels and producing anti-inflammatory and analgesic effects in preclinical studies. Supplied as a white to off-white solid suitable for biochemical and in vivo experiments.
- Selective, irreversible FAAH inhibition.
- Carbamylates the catalytic serine of FAAH.
- Demonstrated anti-inflammatory and analgesic effects in preclinical models.
- Available as a high-purity solid (>98%).
- Suitable for biochemical and in vivo neuroscience research.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.